Effectiveness of interventions of specific complaints of the arm, neck, or shoulder (CANS): Musculoskeletal disorders of the hand

Clinical Journal of Pain

Volumn 25, Issue 6, 2009, Pages 537-552

  Van Middelkoop, Marienke ^a   Huisstede, Bionka M A ^a   Glerum, Suzanne ^a   Koes, Bart W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

CANS; De Quervain disease; Dupuytren's contracture; Raynaud disease; Treatment outcome; Trigger Digit

Indexed keywords

BUFLOMEDIL; CALCIUM CHANNEL BLOCKING AGENT; GINKGO BILOBA EXTRACT; GLYCERYL TRINITRATE; KETANSERIN; PROZASIN; STEROID; UNCLASSIFIED DRUG;

BEHAVIOR THERAPY; COMPRESSION THERAPY; DRUG EFFICACY; DRUG TOLERABILITY; DUPUYTREN CONTRACTURE; HAND DISEASE; HAND SURGERY; HUMAN; LOW LEVEL LASER THERAPY; MUSCULOSKELETAL DISEASE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; TEMPERATURE;

EID: 67649516373     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e31819ff52c     Document Type: Review

References (41)

1. Bot SD, van der Waal JM, Terwee CB, et al. Incidence and prevalence of complaints of the neck and upper extremity in general practice. Ann Rheum Dis. 2005;64:118-123.
2. Huisstede BM, Wijnhoven HA, Bierma-Zeinstra SM, et al. Prevalence and characteristics of complaints of the arm, neck, and/or shoulder (CANS) in the open population. Clin J Pain. 2008;24:253-259.
3. Huisstede BM, Miedema HS, Verhagen AP, et al. Multi-disciplinary consensus on terminology and classification of complaints of arm, neck and/or shoulder. Occup Environ Med. 2007;64:313-319. Epub 2006 Oct 16.
4. van Tulder M, Furlan A, Bombardier C, et al. Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine. 2003;28:1290-1299.
5. Boutron I, Moher D, Tugwell P, et al. A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus. J Clin Epidemiol. 2005;58: 1233-1240.
6. Slavin RE. Best evidence synthesis: an intelligent alternative to meta-analysis. J Clin Epidemiol. 1995;48:9-18.
7. Ko GD, Berbrayer D. Effect of ceramic-impregnated "thermoflow" gloves on patients with Raynaud's syndrome: randomized, placebo-controlled study. Altern Med Rev. 2002;7: 328-335.
8. Vayssairat M. Controlled multicenter double blind trial of an oral analog of prostacyclin in the treatment of primary Raynaud's phenomenon. French Microcirculation Society Multicentre Group for the Study of Vascular Acrosyndromes. J Rheumatol. 1996;23:1917-1920.
9. Murphy D, Failla JM, Koniuch MP. Steroid versus placebo injection for trigger finger. J Hand Surg [Am]. 1995;20: 628-631.
10. Thompson AE, Pope JE. Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis. Rheumatology (Oxford). 2005;44:145-150.
11. Teh LS, Manning J, Moore T, et al. Sustained-release transdermal glyceryl trinitrate patches as a treatment for primary and secondary Raynaud's phenomenon. Br J Rheumatol. 1995;34:636-641.
12. Appiah R, Hiller S, Caspary L, et al. Treatment of primary Raynaud's syndrome with traditional Chinese acupuncture. J Intern Med. 1997;241:119-124.
13. Hirschl M, Katzenschlager R, Ammer K, et al. Double-blind, randomised, placebo controlled low level laser therapy study in patients with primary Raynaud's phenomenon. Vasa. 2002; 31:91-94.
14. Hirschl M, Katzenschlager R, Francesconi C, et al. Low level laser therapy in primary Raynaud's phenomenon - results of a placebo controlled, double blind intervention study. J Rheumatol. 2004;31:2408-2412.
15. Mohrland JS, Porter JM, Smith EA, et al. A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome. Ann Rheum Dis. 1985;44:754-760.
16. Challenor VF, Waller DG, Hayward RA, et al. Subjective and objective assessment of enalapril in primary Raynaud's phenomenon. Br J Clin Pharmacol. 1991;31:477-480.
17. Rustin MH, Grimes SM, Kovacs IB, et al. A double blind trial of UK-38, 485, an orally active thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome. Eur J Clin Pharmacol. 1984;27:61-65.
18. van de Wal HJ, Wijn PF, van Lier HJ, et al. The effectiveness of ketanserin in patients with primary Raynaud's phenomenon. A randomized, double blind, placebo controlled study. Int Angiol. 1987;6:313-322.
19. Nielsen SL, Vitting K, Rasmussen K. Prazosin treatment of primary Raynaud's phenomenon. Eur J Clin Pharmacol. 1983; 24:421-423.
20. Brotzu G, Falchi S, Mannu B, et al. The importance of presynaptic beta receptors in Raynaud's disease. J Vasc Surg. 1989;9:767-771.
21. Rustin MH, Almond NE, Beacham JA, et al. The effect of captopril on cutaneous blood flow in patients with primary Raynaud's phenomenon. Br J Dermatol. 1987;117:751-758.
22. Sunderland GT, Belch JJ, Sturrock RD, et al. A double blind randomised placebo controlled trial of hexopal in primary Raynaud's disease. Clin Rheumatol. 1988;7:46-49.
23. Le Quentrec P, Lefebvre ML. Double-blind placebo-controlled trial of buflomedil in the treatment of Raynaud's phenomenon: six-month follow-up. Angiology. 1991;42:289-295.
24. de Backer TL, Bogaert M, Vander Stichele R. Buflomedil for intermittent claudication. Cochrane Database Syst Rev. 2008: CD000988.
25. Jayson MI, Holland CD, Keegan A, et al. A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis. Ann Rheum Dis. 1991;50:41-47.
26. DiGiacomo RA, Kremer JM, Shah DM. Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study. Am J Med. 1989; 86:158-164.
27. von Schacky C, Fischer S, Weber PC. Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest. 1985;76:1626-1631.
28. Muir AH, Robb R, McLaren M, et al. The use of Ginkgo biloba in Raynaud's disease: a double-blind placebo-controlled trial. Vasc Med. 2002;7:265-267.
29. Investigators RSTS. Comparison of sustained-release nifedipine and temperature biofeedback for treatment of primary Raynaud phenomenon. Results from a randomized clinical trial with 1-year follow-up. Arch Intern Med. 2000;160: 1101-1108.
30. Middaugh SJ, Haythornthwaite JA, Thompson B, et al. The Raynaud's Treatment Study: biofeedback protocols and acquisition of temperature biofeedback skills. Appl Psychophysiol Biofeedback. 2001;26:251-278.
31. Surwit RS, Pilon RN, Fenton CH. Behavioral treatment of Raynaud's disease. J Behav Med. 1978;1:323-335.
32. Freedman RR, Ianni P, Wenig P. Behavioral treatment of Raynaud's disease. J Consult Clin Psychol. 1983;51:539-549.
33. Bhatia R, Blackshaw G, Barr V, et al. Comparative study of "staples versus sutures" in skin closure following Dupuytren's surgery. J Hand Surg [Br]. 2002;27:53-54.
34. Hazarika EZ, Knight MT, Frazer-Moodie A. The effect of intermittent pneumatic compression on the hand after fas-ciectomy. Hand. 1979;11:309-314.
35. Citron ND, Nunez V. Recurrence after surgery for Dupuytren's disease: a randomized trial of two skin incisions. J Hand Surg [Br]. 2005;30:563-566.
36. Bulstrode NW, Bisson M, Jemec B, et al. A prospective randomised clinical trial of the intra-operative use of 5-fluorouracil on the outcome of dupuytren's disease. J Hand Surg [Br]. 2004;29:18-21.
37. Jirarattanaphochai K, Saengnipanthkul S, Vipulakorn K, et al. Treatment of de Quervain disease with triamcinolone injection with or without nimesulide. A randomized, double-blind, placebo-controlled trial. J Bone Joint Surg Am. 2004;86-A: 2700-2706.
38. Avci S, Yilmaz C, Sayli U. Comparison of nonsurgical treatment measures for de Quervain's disease of pregnancy and lactation. J Hand Surg [Am]. 2002;27:322-324.
39. van Tulder M, Furlan A, Bombardier C, et al, Editorial Board of the Cochrane Collaboration Back Review G. Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine. 2003;28: 1290-1299.
40. Urquhart DM, Hoving JL, Assendelft WW, et al. Antidepres-sants for non-specific low back pain. Cochrane Database Syst Rev. 2008:CD001703.
41. Karjalainen K, Malmivaara A, van Tulder M, et al. Biopsychosocial rehabilitation for upper limb repetitive strain injuries in working age adults. Cochrane Database Syst Rev. 2000:CD002269.